E
Eli Lilly and Company (LLY)
NYQ – Real vaqt narxi. Valyuta: USD
1208.12
+80.43 (7.13%)
Yopilishda: Jun 26, 2026, 4:05 PM EDT
1211.00
+2.88 (0.24%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NYQ – Real vaqt narxi. Valyuta: USD
1208.12
+80.43 (7.13%)
Yopilishda: Jun 26, 2026, 4:05 PM EDT
1211.00
+2.88 (0.24%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Eli Lilly and Company Qoʻshma Shtatlar, Yevropa, Xitoy, Yaponiya va xalqaro miqyosda inson farmatsevtika mahsulotlarini kashf qiladi, ishlab chiqadi, ishlab chiqaradi va sotadi. Kompaniya diabet uchun Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500; 2-toifa diabet uchun Jardiance, Mounjaro va Trulicity; va semizlik uchun Zepboundni oʻz ichiga olgan kardio-metabolik salomatlik mahsulotlarini taklif qiladi. U, shuningdek, oshqozon rakining ikkinchi bosqichli davolash uchun Cyramza; kolorektal va bosh va boʻyin saratoni uchun Erbitux; koʻkrak bezi saratoni uchun Inluriyo; surunkali limfotsitik leykemiya yoki kichik limfotsitik limfoma uchun Jaypirca; metastatik NSCLCni davolash uchun Retevmo; klassik Xojkin limfomasi uchun TYVYT; va koʻkrak bezi saratoni uchun Verzenio kabi onkologiya mahsulotlarini taqdim etadi. Bundan tashqari, kompaniya ogʻir atopik dermatit uchun Ebglyss; revmatoid artrit, atopik dermatit, ogʻir soch toʻkilishi va COVID-19 uchun Olumiant; yarali kolit uchun Omvoh; va blyashka psoriazi, psoriatik artrit, ankilozan spondilit va rentgenologik boʻlmagan oʻq spondiloartrit uchun Taltzni oʻz ichiga olgan immunologiya mahsulotlarini taklif etadi. Bundan tashqari, u migrenni oldini olish va epizodik klaster bosh ogʻrigʻi uchun Emgality, shuningdek, Altsgeymer kasalligining simptomatik davolash uchun Kisubla'ni taqdim etadi. Kompaniya Jardiance mahsulotlari oilasi uchun Boehringer Ingelheim Pharmaceuticals, Inc. bilan; va lebrikizumab uchun F. Hoffmann-La Roche Ltd va Genentech, Inc. bilan hamkorlik qiladi, shuningdek, Ebglyss uchun Almirall, S.A. bilan; va orforglipron uchun Chugai Pharmaceutical Co., Ltd bilan; va aniqlanmagan monogen buyrak kasalliklari uchun terapiyalarni kashf qilish va rivojlantirish boʻyicha Ascidian Therapeutics bilan strategik hamkorlikni amalga oshiradi. Eli Lilly and Company 1876 yilda tashkil etilgan va uning shtab-kvartirasi Indiana shtatining Indianapolis shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Daniel M. Skovronsky M.D., Ph.D. | Chief Scientific & Product Officer and President of Lilly Research Laboratories |
| Mr. David A. Ricks | Chairman & CEO |
| Mr. Diogo Rau | Executive VP and Chief Information & Digital Officer |
| Mr. Donald A. Zakrowski | Senior VP of Finance & Chief Accounting Officer |
| Mr. Eric Dozier | Executive VP & Chief People Officer |
| Mr. Ilya Yuffa | Executive VP and President of Lilly USA & Global Customer Capabilities |
| Mr. Jacob S. Van Naarden | Executive VP, President of Lilly Oncology & Head of Corporate Business Development |
| Mr. Lucas E. Montarce | Executive VP & CFO |
| Mr. Michael Czapar | Director of Investor Relations |
| Ms. Anat Hakim J.D. | Executive VP, General Counsel & Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-23 | 11-K | lly-20260623.htm |
| 2026-05-20 | 8-K | d148580d8k.htm |
| 2026-05-11 | SD | formsd2026.htm |
| 2026-05-07 | 8-K | lly-20260504.htm |
| 2026-04-30 | 10-Q | lly-20260331.htm |
| 2026-03-31 | DFAN14A | d111268ddfan14a.htm |
| 2026-03-20 | DEF 14A | lly-20260317.htm |
| 2026-03-06 | PRE 14A | lly-20260306.htm |
| 2026-02-12 | 10-K | lly-20251231.htm |
| 2026-02-04 | 8-K | lly-20260204.htm |